The National Institute of Allergy and Infectious Diseases (NIAID) is offering the ‘Molecular Mechanisms of Combination Adjuvants (MMCA)(U01)’ grant to support studies investigating the mechanism of action of combining two or more vaccine adjuvants. Applicants must utilize adjuvants with proven immune-boosting activity to enhance the effectiveness of vaccines. This grant aims to advance NIAID’s adjuvant research by analyzing the immune-stimulating properties of novel adjuvant combinations. Through the Cooperative Agreement grant mechanism, researchers can align their efforts with NIAID’s overall adjuvant research goals, with the ultimate objective of enhancing vaccine immunogenicity and minimizing reactogenicity concerns.
Opportunity ID: 273673
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-15-005 |
| Funding Opportunity Title: | Molecular Mechanisms of Combination Adjuvants (MMCA)(U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy, Immunology and Transplantation Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 10, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 09, 2015 |
| Current Closing Date for Applications: | Jul 09, 2015 |
| Archive Date: | Aug 09, 2015 |
| Estimated Total Program Funding: | $4,000,000 |
| Award Ceiling: | $350,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Special district governments Independent school districts Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits applications that propose studies of the mechanism of action of a combination of two or more vaccine adjuvants (combination adjuvant). Adjuvants that are used in these studies must already have shown immune boosting activity when used individually in licensed or unlicensed vaccines (e.g. experimental or candidate vaccines).
The purpose of this FOA is to build upon the investment the NIAID has already made into adjuvant research, by combining previously identified and characterized adjuvants and characterizing their immune stimulating activity. The Cooperative Agreement grant mechanism allows for coordination of these research efforts with NIAIDs overall adjuvant research objectives. The long-term goal is to promote the development of novel adjuvant combinations which will improve the immunogenicity of vaccines while addressing concerns related to reactogenicity. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-15-005.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00213986 | Jun 09, 2015 | Jul 09, 2015 | View |
Package 1
Mandatory forms
273673 RR_SF424_2_0-2.0.pdf
273673 PHS398_ResearchPlan_2_0-2.0.pdf
273673 PHS398_CoverPageSupplement_2_0-2.0.pdf
273673 RR_KeyPersonExpanded_2_0-2.0.pdf
273673 RR_OtherProjectInfo_1_3-1.3.pdf
273673 PerformanceSite_2_0-2.0.pdf
Optional forms
273673 RR_SubawardBudget30_1_3-1.3.pdf
273673 PlannedReport-1.0.pdf
273673 PHS398_CumulativeInclusionReport-1.0.pdf
273673 PHS398_ModularBudget_1_2-1.2.pdf
273673 RR_Budget_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
